Microbiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Microbiology 147 (2001), 811-819
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Inoue, K.
Right arrow Articles by Oguma, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Inoue, K.
Right arrow Articles by Oguma, K.
Agricola
Right arrow Articles by Inoue, K.
Right arrow Articles by Oguma, K.
Microbiology (2001), 147, 811-819.
© 2001 Society for General Microbiology


Biochemistry

Clostridium botulinum type A haemagglutinin-positive progenitor toxin (HA+-PTX) binds to oligosaccharides containing Galß1-4GlcNAc through one subcomponent of haemagglutinin (HA1)

Kaoru Inoue1, Yukako Fujinaga1, Koichi Honke2, Hideyuki Arimitsu1, Nazira Mahmut1, Yoshihiko Sakaguchi1, Tohru Ohyama3, Toshihiro Watanabe3, Katsuhiro Inoue3 and Keiji Oguma1

Department of Bacteriology, Okayama University Medical School, 2-5-1 Shikata-cho, Okayama 700-8558, Japan1
Department of Biochemistry, Osaka University Medical School, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan2
Department of Food Science, Faculty of Bioindustry, Tokyo University of Agriculture, 196 Yasaka, Abashiri099-2422, Japan3

Author for correspondence: Keiji Oguma. Tel: +81 86 235 7162. Fax: +81 86 235 7162. e-mail: kuma{at}med.okayama-u.ac.jp

Haemagglutinin (HA) activity of Clostridium botulinum type A 19S and 16S toxins (HA-positive progenitor toxin; HA+-PTX) was characterized. HA titres against human erythrocytes of HA+-PTX were inhibited by the addition of lactose, D-galactose, N-acetyl-D-galactosamine and D-fucose to the reaction mixtures. A direct glycolipid binding test demonstrated that type A HA+-PTX strongly bound to paragloboside and some neutral glycolipids, but did not bind to gangliosides. Type A HA+-PTX also bound to asialoglycoproteins (asialofetuin, neuraminidase-treated transferrin), but not to sialoglycoproteins (fetuin, transferrin). Although glycopeptidase F treatment of asialofetuin abolished the binding of HA+-PTX, endo-{alpha}-N-acetylgalactosaminidase treatment did not. Thus these results can be interpreted as indicating that type A HA+-PTX detects and binds to Galß1-4GlcNAc in paragloboside and the N-linked oligosaccharides of glycoproteins. Regardless of neuraminidase treatment, type A HA+-PTX bound to glycophorin A which is a major sialoglycoprotein on the surface of erythrocytes. Both native glycophorin A and neuraminidase-treated glycophorin A inhibited the binding of erythrocytes to type A HA+-PTX. Since the N-linked oligosaccharide of glycophorin A is di-branched and more than 50% of this sugar chain is monosialylated, type A HA+-PTX probably bound to the unsialylated branch of the N-linked oligosaccharide of glycophorin A and agglutinated erythrocytes. One subcomponent of HA, designated HA1, did not agglutinate native erythrocytes, although it did bind to erythrocytes, paragloboside and asialoglycoproteins in a manner quite similar to that of HA+-PTX. These results indicate that type A HA+-PTX binds to oligosaccharides through HA1.

Keywords: binding, sugar chain, glycolipid, glycoprotein

Abbreviations: CBB, Coomassie brilliant blue; HA, haemagglutinin; HA+-PTX, haemagglutinin-positive progenitor toxin; PAS, periodic acid–Schiff




This article has been cited by other articles:


Home page
MicrobiologyHome page
J.-C. Lee, K. Yokota, H. Arimitsu, H.-J. Hwang, Y. Sakaguchi, J. Cui, K. Takeshi, T. Watanabe, T. Ohyama, and K. Oguma
Production of anti-neurotoxin antibody is enhanced by two subcomponents, HA1 and HA3b, of Clostridium botulinum type B 16S toxin-haemagglutinin
Microbiology, November 1, 2005; 151(11): 3739 - 3747.
[Abstract] [Full Text] [PDF]


Home page
MicrobiologyHome page
K. Inoue, M. Sobhany, T. R. Transue, K. Oguma, L. C. Pedersen, and M. Negishi
Structural analysis by X-ray crystallography and calorimetry of a haemagglutinin component (HA1) of the progenitor toxin from Clostridium botulinum
Microbiology, December 1, 2003; 149(12): 3361 - 3370.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
H. Arimitsu, K. Inoue, Y. Sakaguchi, J. Lee, Y. Fujinaga, T. Watanabe, T. Ohyama, R. Hirst, and K. Oguma
Purification of Fully Activated Clostridium botulinum Serotype B Toxin for Treatment of Patients with Dystonia
Infect. Immun., March 1, 2003; 71(3): 1599 - 1603.
[Abstract] [Full Text] [PDF]


Home page
J Med MicrobiolHome page
N. MAHMUT, K. INOUE, Y. FUJINAGA, H. ARIMITSU, Y. SAKAGUCHI, L. HUGHES, R. HIRST, T. MURPHY, T. TSUJI, T. WATANABE, et al.
Mucosal immunisation with Clostridium botulinum type C 16 S toxoid and its non-toxic component
J. Med. Microbiol., October 1, 2002; 51(10): 813 - 820.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 2001 Society for General Microbiology.